Guanfacine Potentiates the Activation of Prefrontal Cortex Evoked by Warning Signals

Biological Psychiatry

Volumn 66, Issue 4, 2009, Pages 307-312

  Clerkin, Suzanne M ^a   Schulz, Kurt P ^a   Halperin, Jeffrey M ^a,b   Newcorn, Jeffrey H ^a   Ivanov, Iliyan ^a   Tang, Cheuk Y ^a   Fan, Jin ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Adrenergic receptors; adults; fMRI; guanfacine; prefrontal cortex; warning cues

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; GUANFACINE; PLACEBO;

ADULT; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; IMAGING SYSTEM; MALE; NEUROIMAGING; NORMAL HUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOMETRY; RESPONSE TIME; SINGLE DRUG DOSE; TASK PERFORMANCE;

ADULT; BRAIN; BRAIN MAPPING; CUES; DOUBLE-BLIND METHOD; FEMALE; GUANFACINE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVE NET; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; REACTION TIME; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 67651023724     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.04.013     Document Type: Article

References (43)

1. Posner M.I. Measuring alertness. Ann N Y Acad Sci 1129 (2008) 193-199
2. Fan J., McCandliss B.D., Fossella J., Flombaum J.I., and Posner M.I. The activation of attentional networks. Neuroimage 26 (2005) 471-479
3. Fan J., Kolster R., Ghajar J., Suh M., Knight R.T., Sarkar R., et al. Response anticipation and response conflict: An event-related potential and functional magnetic resonance imaging study. J Neurosci 27 (2007) 2272-2282
4. Dosenbach N.U., Fair D.A., Miezin F.M., Cohen A.L., Wenger K.K., Dosenbach R.A., et al. Distinct brain networks for adaptive and stable task control in humans. Proc Natl Acad Sci U S A 104 (2007) 11073-11078
5. Goldman-Rakic P.S. Architecture of the prefrontal cortex and the central executive. Ann N Y Acad Sci 769 (1995) 71-83
6. Kritzer M.F., and Goldman-Rakic P.S. Intrinsic circuit organization of the major layers and sublayers of the dorsolateral prefrontal cortex in the rhesus monkey. J Comp Neurol 359 (1995) 131-143
7. Arnsten A.F., and Li B.M. Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57 (2005) 1377-1384
8. Aston-Jones G., and Cohen J.D. Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance. J Comp Neurol 493 (2005) 99-110
9. Rajkowski J., Majczynski H., Clayton E., and Aston-Jones G. Activation of monkey locus coeruleus neurons varies with difficulty and performance in a target detection task. J Neurophysiol 92 (2004) 361-371
10. Branchereau P., Van Bockstaele E.J., Chan J., and Pickel V.M. Pyramidal neurons in rat prefrontal cortex show a complex synaptic response to single electrical stimulation of the locus coeruleus region: Evidence for antidromic activation and GABAergic inhibition using in vivo intracellular recording and electron microscopy. Synapse 22 (1996) 313-331
11. Aoki C., Go C.G., Venkatesan C., and Kurose H. Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity. Brain Res 650 (1994) 181-204
12. Wang M., Ramos B.P., Paspalas C.D., Shu Y., Simen A., Duque A., et al. Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell 129 (2007) 397-410
13. MacDonald E., Kobilka B.K., and Scheinin M. Gene targeting-homing in on alpha 2-adrenoceptor-subtype function. Trends Pharmacol Sci 18 (1997) 211-219
14. Barth A.M., Vizi E.S., Zelles T., and Lendvai B. Alpha2-adrenergic receptors modify dendritic spike generation via HCN channels in the prefrontal cortex. J Neurophysiol 99 (2008) 394-401
15. Avery R.A., Franowicz J.S., Studholme C., van Dyck C.H., and Arnsten A.F. The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task. Neuropsychopharmacology 23 (2000) 240-249
16. Arnsten A.F., Cai J.X., and Goldman-Rakic P.S. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: Evidence for alpha-2 receptor subtypes. J Neurosci 8 (1988) 4287-4298
17. Arnsten A.F., and Contant T.A. Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task. Psychopharmacology (Berl) 108 (1992) 159-169
18. Jakala P., Riekkinen M., Sirvio J., Koivisto E., Kejonen K., Vanhanen M., et al. Guanfacine, but not clonidine, improves planning and working memory performance in humans. Neuropsychopharmacology 20 (1999) 460-470
19. Ivanov A., and Aston-Jones G. Extranuclear dendrites of locus coeruleus neurons: Activation by glutamate and modulation of activity by alpha adrenoceptors. J Neurophysiol 74 (1995) 2427-2436
20. Boehm S., and Huck S. Inhibition of N-type calcium channels: The only mechanism by which presynaptic alpha 2-autoreceptors control sympathetic transmitter release. Eur J Neurosci 8 (1996) 1924-1931
21. Witte E.A., and Marrocco R.T. Alteration of brain noradrenergic activity in rhesus monkeys affects the alerting component of covert orienting. Psychopharmacology (Berl) 132 (1997) 315-323
22. Coull J.T., Nobre A.C., and Frith C.D. The noradrenergic alpha2 agonist clonidine modulates behavioural and neuroanatomical correlates of human attentional orienting and alerting. Cereb Cortex 11 (2001) 73-84
23. Beck A.T., Epstein N., Brown G., and Steer R.A. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol 56 (1988) 893-897
24. Steer R.A., Ball R., Ranieri W.F., and Beck A.T. Dimensions of the Beck Depression Inventory-II in clinically depressed outpatients. J Clin Psychol 55 (1999) 117-128
25. Conners C.K., Erhardt D., and Sparrow M.A. Conners' Adult ADHD Rating Scales (CAARS) (1999), Multi-Health Systems, New York
26. Wechsler D. Wechsler Abbreviated Scale of Intelligence (1999), The Psychological Corporation, San Antonio, TX
27. Halperin J.M., Matier K., Bedi G., Sharma V., and Newcorn J.H. Specificity of inattention, impulsivity, and hyperactivity to the diagnosis of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 31 (1992) 190-196
28. Halperin J.M., Newcorn J.H., Matier K., Sharma V., McKay K.E., and Schwartz S. Discriminant validity of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 32 (1993) 1038-1043
29. Friston K.J., Fletcher P., Josephs O., Holmes A., Rugg M.D., and Turner R. Event-related fMRI: Characterizing differential responses. Neuroimage 7 (1998) 30-40
30. Johnstone T., Ores W.K.S., Greischar L.L., Alexander A.L., Fox A.S., Davidson R.J., et al. Motion correction and the use of motion covariates in multiple-subject fMRI analysis. Hum Brain Mapp 27 (2006) 779-788
31. Hayasaka S., Phan K.L., Liberzon I., Worsley K.J., and Nichols T.E. Nonstationary cluster-size inference with random field and permutation methods. Neuroimage 22 (2004) 676-687
32. Talairach J., and Tournoux M. Co-Planar Stereotaxic Atlas of the Human Brain (1988), Thieme Medical, New York
33. Jakala P., Riekkinen M., Sirvio J., Koivisto E., and Riekkinen Jr. P. Clonidine, but not guanfacine, impairs choice reaction time performance in young healthy volunteers. Neuropsychopharmacology 21 (1999) 495-502
34. Thiel C.M., and Fink G.R. Effects of the cholinergic agonist nicotine on reorienting of visual spatial attention and top-down attentional control. Neuroscience 152 (2008) 381-390
35. Wilkinson D., and Halligan P. The relevance of behavioural measures for functional-imaging studies of cognition. Nat Rev 5 (2004) 67-73
36. Scahill L., Chappell P.B., Kim Y.S., Schultz R.T., Katsovich L., Shepherd E., et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158 (2001) 1067-1074
37. Physicians' Desk Reference. Physicians' Desk Reference. 63rd ed. (2009), Thomson Corp, Montvale, NJ
38. Casey B.J. Neuroscience. Windows into the Human Brain. Science 296 (2002) 1408-1409
39. Carr D.B., Andrews G.D., Glen W.B., and Lavin A. alpha2-Noradrenergic receptors activation enhances excitability and synaptic integration in rat prefrontal cortex pyramidal neurons via inhibition of HCN currents. J Physiol 584 (2007) 437-450
40. Logothetis N.K. The neural basis of the blood-oxygen-level-dependent functional magnetic resonance imaging signal. Philos Trans R Soc Lond 357 (2002) 1003-1037
41. Viswanathan A., and Freeman R.D. Neurometabolic coupling in cerebral cortex reflects synaptic more than spiking activity. Nat Neurosci 10 (2007) 1308-1312
42. Brennan A.R., and Arnsten A.F. Neuronal mechanisms underlying attention deficit hyperactivity disorder: The influence of arousal on prefrontal cortical function. Ann N Y Acad Sci 1129 (2008) 236-245
43. Arnsten A.F., Scahill L., and Findling R.L. alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: Emerging concepts from new data. J Child Adolesc Psychopharmacol 17 (2007) 393-406